EXTI - only public co. developing liver device Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : EXTI - only public co. developing liver device

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Danny Kim who started this subject	5/9/2004 12:19:01 AM
From: MaxLeverage	of 1063

augustachronicle.com DNA experiment fixes mutant gene Web posted December 3, 1998 ``This is a completely new kind of 21st-century gene therapy,'' said Dr. Jayanta Roy-Chowdhury, a professor of medicine and molecular genetics at Albert Einstein College of Medicine in the Bronx. ``It's remarkable.'' His lab has been the first to succeed in delivering this so-called chimera molecule -- part RNA, part DNA -- into animals and finding that it helped the body correct the defect by replacing a missing piece of the gene. note> Dr. Roy-Chowdhury was one of the original founders of Multicell Associates.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next